The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bel'skaia G.N.

Kafedra nevrologii fakul'teta poslevuzovskogo i dopolnitel'nogo professional'nogo obrazovaniia GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennykh meditsinskiĭ universitet" Minzdrava Rossii, Cheliabinsk

Semenova M.P.

Nevrologicheskoe otdelenie dlia bol'nykh s narusheniem mozgovogo krovoobrashcheniia GBUZ "Oblastnaia klinicheskaia bol'nitsa #3", Cheliabinsk

Popov D.V.

Nevrologicheskoe otdelenie dlia bol'nykh s narusheniem mozgovogo krovoobrashcheniia GBUZ "Oblastnaia klinicheskaia bol'nitsa #3", Cheliabinsk

Stepanova S.B.

Kafedra nevrologii fakul'teta poslevuzovskogo i dopolnitel'nogo professional'nogo obrazovaniia GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennykh meditsinskiĭ universitet" Minzdrava Rossii, Cheliabinsk

Hemorrhagic syndrome after the treatment with peroral anticoagulants - antagonists of vitamin K

Authors:

Bel'skaia G.N., Semenova M.P., Popov D.V., Stepanova S.B.

More about the authors

Read: 4061 times


To cite this article:

Bel'skaia GN, Semenova MP, Popov DV, Stepanova SB. Hemorrhagic syndrome after the treatment with peroral anticoagulants - antagonists of vitamin K. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(9):79‑82. (In Russ.)

Recommended articles:
Hemo­rrhagic and thro­mboembolic complications in catheter abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):628-633

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.